Altitude sickness can absolutely be dangerous, though most cases are mild and resolve on their own. The real risk comes when early symptoms are ignored and a person keeps climbing. Mild altitude sickness is common and uncomfortable. Its two severe forms, involving fluid buildup in the lungs or brain, can be fatal within hours if left untreated.
Mild Altitude Sickness vs. Its Severe Forms
Altitude sickness exists on a spectrum, and understanding where you fall on it matters more than any single symptom. The mild version, acute mountain sickness (AMS), affects a large percentage of unacclimatized travelers who sleep above 8,000 feet. Nearly everyone who ascends quickly to 11,000 feet will develop it. Symptoms include headache, nausea, lightheadedness, and shortness of breath. It’s unpleasant but not life-threatening on its own.
The danger begins when AMS progresses into one of two severe conditions:
- High-altitude pulmonary edema (HAPE): Fluid accumulates in the lungs. You may feel extreme breathlessness even at rest, develop a persistent cough, and notice a gurgling sensation when breathing. Untreated HAPE carries a mortality rate as high as 50%, making it the most common cause of death from high-altitude exposure.
- High-altitude cerebral edema (HACE): Fluid accumulates in the brain. Early signs are intense headache and fatigue, but as it worsens you lose coordination, become confused, and may struggle to walk in a straight line. HACE is essentially end-stage altitude sickness and can progress to coma and death.
Both severe forms are rare below 14,000 feet. At that threshold and above, HAPE occurs in roughly 1 out of every 100 travelers. To put the lower-altitude risk in perspective, the incidence of HAPE among skiers in Colorado is approximately 1 in 10,000.
What Happens Inside Your Body
At high altitude, the air contains less oxygen per breath. Your body responds by increasing heart rate and breathing rate, which works well enough if you give it time. Problems start when you ascend faster than your body can adjust.
In HAPE, blood vessels in the lungs constrict unevenly in response to low oxygen, forcing fluid out of the bloodstream and into the air sacs where gas exchange happens. Your lungs essentially start filling with liquid, which makes the oxygen shortage even worse in a dangerous feedback loop.
In HACE, the process targets the brain. Cells in the brain begin swelling as they lose the ability to regulate the balance of salt and water across their membranes. This pulls additional fluid from blood vessels into brain tissue. In severe cases, tiny blood vessels in the brain can rupture entirely. The good news is that the swelling is usually reversible if caught early, but hemorrhaging signals a more serious breakdown.
How Quickly It Becomes Dangerous
AMS symptoms typically appear within 6 to 12 hours of reaching a new altitude, often hitting hardest on the first night. Most people feel better within a day or two if they stop ascending and let their bodies catch up.
The transition from annoying to dangerous is what catches people off guard. HACE often develops as a progression from worsening AMS over one to three days. HAPE can appear more suddenly, sometimes within the first two to four days at a new elevation, and occasionally strikes people who felt fine up to that point. The critical window is the first 72 hours after a significant gain in sleeping altitude.
The single most important warning sign is a loss of coordination. If you or a hiking partner can’t walk heel-to-toe in a straight line, that suggests brain swelling has begun. Severe breathlessness at rest, especially with a wet cough, signals fluid in the lungs. Either situation demands immediate descent.
Who Faces the Greatest Risk
The biggest risk factor isn’t your fitness level or age. It’s your rate of ascent. Someone in excellent cardiovascular shape who flies from sea level to a trailhead at 12,000 feet and starts hiking uphill the same day faces a higher risk than an average hiker who spent several days acclimatizing at 9,000 feet first.
A personal history of altitude sickness is one of the strongest predictors of getting it again. If you’ve had HAPE or HACE before, your risk of a repeat episode on a similar ascent profile is significantly elevated. People who live at low elevations and travel to high-altitude destinations for skiing, trekking, or mountaineering are the most common candidates simply because the altitude change is abrupt.
Prevention Through Pacing
The most effective prevention strategy is gradual ascent. Above 8,000 feet, the standard recommendation is to increase your sleeping altitude by no more than about 1,000 to 1,500 feet per day, with a rest day (no altitude gain) every three to four days. This gives your body time to produce more red blood cells and adjust how efficiently it uses oxygen.
For people on a tight schedule who can’t ascend gradually, a prescription medication called acetazolamide can help prevent AMS and HACE. It works by changing the acidity of your blood, which stimulates deeper breathing and speeds acclimatization. The Wilderness Medical Society recommends starting it the day before ascent, though it still offers benefit if started on the day of travel. It should be continued for two days after reaching your target elevation, or longer if you ascended faster than recommended.
Hydration and avoiding alcohol during the first couple of days at altitude are helpful supporting strategies, but they’re no substitute for a sensible ascent rate.
When Descent Is the Only Treatment
For mild AMS, you can stay at your current altitude, rest, hydrate, and use over-the-counter pain relievers for headache. Most people improve within 24 to 48 hours. The non-negotiable rule: do not ascend further while symptomatic.
For HAPE or HACE, descent is the definitive treatment and should begin as soon as symptoms are recognized. Even dropping 1,000 to 3,000 feet can produce dramatic improvement. Supplemental oxygen helps if available, but it’s not a substitute for getting lower. In remote mountaineering settings where immediate descent isn’t possible, portable pressurized bags can simulate a lower altitude and buy time.
The people who die from altitude sickness are almost always those who continued ascending despite symptoms, were too remote to descend quickly, or didn’t recognize the warning signs. At popular trekking destinations with established trails and accessible lower elevations, deaths from altitude illness are rare precisely because descent is straightforward. The risk climbs sharply on high-altitude mountaineering expeditions where descending quickly may be physically impossible due to terrain or weather.